Jointown Pharmaceutical Group Co., Ltd (SHA:600998)

SHA:600998 Revenue

Jointown Pharmaceutical Group had revenue of 42.02B CNY in the quarter ending March 31, 2025, with 3.82% growth. This brings the company's revenue in the last twelve months to 153.35B, up 3.26% year-over-year. In the year 2024, Jointown Pharmaceutical Group had annual revenue of 151.81B with 1.11% growth.

• Revenue (ttm): 153.35B
• Revenue Growth: +3.26%
• P/S Ratio: 0.17
• Revenue / Employee: 5.08M
• Employees: 30,169
• Market Cap: 26.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	151.81B	1.67B	1.11%
Dec 31, 2023	150.14B	9.72B	6.92%
Dec 31, 2022	140.42B	18.02B	14.72%
Dec 31, 2021	122.41B	11.55B	10.42%
Dec 31, 2020	110.86B	11.36B	11.42%